机器人对比胸腔镜肺段切除术治疗早期肺癌的早期结局:多中心倾向性评分匹配分析
该多中心回顾性研究纳入774例早期非小细胞肺癌患者,比较机器人辅助与胸腔镜肺段切除术的围术期结局。倾向性评分匹配后每组257例,两组在手术时间、出血量、并发症率和住院时间上无显著差异,但机器人组费用更高且N1淋巴结清扫数量更多。结论认为两种术式安全可行,机器人可能带来更好的N1淋巴结清扫。
要点
- 机器人组与胸腔镜组围术期结局无显著差异。
- 机器人组费用显著高于胸腔镜组。
- 机器人组N1淋巴结及站数更多。
核心结论
- 机器人与胸腔镜肺段切除术治疗早期NSCLC均安全可行。
- 机器人入路可能带来更好的N1淋巴结清扫。
研究设计与样本
- 回顾性分析3家学术机构2015年6月至2019年8月774例早期NSCLC微创肺段切除术患者,其中机器人组298例、胸腔镜组476例。
- 基于年龄、性别、BMI、FEV1%、吸烟状态、ASA评分、肺段切除类型、肿瘤大小和机构进行倾向性评分匹配,匹配后每组257例。
临床怎么用
- 早期NSCLC肺段切除术可根据技术条件和费用选择机器人或胸腔镜。
- 若关注N1淋巴结清扫,机器人入路可能更具优势。
局限性
- 回顾性研究设计。
- 仅纳入3家学术机构。
- 未报告长期肿瘤学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Anatomical segmentectomy via robotic thoracic surgery and video-assisted thoracic surgery (VATS) are minimally invasive surgical approaches for treatment of early-stage non-small cell lung cancer (NSCLC). However, few research studies have compared early outcomes. METHODS: A retrospective analysis was made of 774 patients, 298 who received robotic and 476 who received VATS, who underwent minimally invasive segmentectomy for early-stage NSCLC at 3 academic institutions between June 2015 and August 2019. Perioperative outcomes were compared after propensity score-matching on the basis of age, gender, body mass index, percent forced expiratory volume in 1 second, smoking status, American Society of Anesthesiologists score, type of segmentectomy, tumor size, and institution. RESULTS: There were 257 patients in each group after propensity score-matching. The baseline characteristics and type of segmentectomy were comparable. Three conversions to thoracotomy occurred in the VATS group, and 1 in the robotic group (P = .624). There was no significant difference in operative time (147.91 ± 52.42 vs 149.23 ± 49.66 minutes; P = .773), blood loss (50 mL [interquartile range (IQR), 50-100 mL] vs 100 mL [IQR, 30-100 mL]; P = .177), rates of overall complications (17.9 vs 14.8%; P = .340), and length of stay (4 days [IQR, 3-5 days] vs 4 days [IQR, 3-5 days]; P = .417) between the robotic and VATS groups, respectively. Robotic segmentectomy was more costly ($12,019.30 ± 1678.30 vs $7834.80 ± 1291.20; P < .001) because of the amortization and consumables of the robotic system. There were a greater number of N1 lymph nodes and N1 stations in the robotic group. CONCLUSIONS: Segmentectomy with robotic and VATS are safe and feasible for early-stage NSCLC treatment. A robotic approach might lead to a better N1 lymph node dissection.
引用
- Zhang Y, Chen C, Hu J, et al. Early outcomes of robotic versus thoracoscopic segmentectomy for early-stage lung cancer: A multi-institutional propensity score-matched analysis. J Thorac Cardiovasc Surg. 2020. PMID: 32113718. doi:10.1016/j.jtcvs.2019.12.112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。